LABORATORY RESEARCH Induction of IL-25 Secretion from Tumor-Associated Fibroblasts Suppresses Mammary Tumor Metastasis Scientists investigated the role of IL-25, an endogenous anticancer factor secreted from tumor-associated fibroblasts, in suppression of mouse 4T1 mammary tumor metastasis. [Nat Commun] Full Article Sensitizing Basal-Like Breast Cancer to Chemotherapy Using Nanoparticles Conjugated with Interference Peptide Researchers propose a novel therapeutic strategy using poly(glycidyl methacrylate) nanoparticles decorated with poly(acrylic acid) that enable dual delivery of docetaxel and interference peptides designed to block or inhibit engrailed 1. [Nanoscale] Abstract Functional Interference in the Bone Marrow Microenvironment by Disseminated Breast Cancer Cells The interaction between disseminated breast cancer cells and the bone marrow microenvironment which harbors them has not been addressed comprehensively. Employing advanced co-culture assays, proteomic studies, organotypic models as well as in vivo xenotransplant models, the authors define the consequences of this interaction on the stromal compartment of bone marrow, affected molecular pathways and subsequent effects on the hematopoietic stem and progenitor cells. [Stem Cells] Abstract The Cellular Distribution of Na+/H+ Exchanger Regulatory Factor 1 Is Determined by the PDZ-I Domain and Regulates the Malignant Progression of Breast Cancer A novel mutation, namely Na+/H+ exchanger regulatory factor 1 (NHERF1) Y24S, was identified in human breast cancer tissues and shown to correspond to a conserved residue in the PDZ-I domain of NHERF1. [Oncotarget] Full Article Overexpression of Caspase 7 Is ERα Dependent to Affect Proliferation and Cell Growth in Breast Cancer Cells by Targeting p21(Cip) Researchers showed that the caspase 7 (CASP7) expression is high in breast carcinoma tissues compared with normal counterpart. The ectopic expression of CASP7 was significantly associated with ERα expression status and persistently elevated in different stages of the breast tumor grades. [Oncogenesis] Full Article Trisubstituted-Imidazoles Induce Apoptosis in Human Breast Cancer Cells by Targeting the Oncogenic PI3K/Akt/mTOR Signaling Pathway Researchers report the synthesis and biological evaluation of imidazoles that induce apoptosis in breast cancer cells by negatively regulating PI3K/Akt/mTOR signaling pathway. [PLoS One] Full Article CLINICAL RESEARCH A Comparison of Proposed Biosimilar LA-EP2006 and Reference Pegfilgrastim for the Prevention of Neutropenia in Patients with Early-Stage Breast Cancer Receiving Myelosuppressive Adjuvant or Neoadjuvant Chemotherapy: Pegfilgrastim Randomized Oncology (Supportive Care) Trial to Evaluate Comparative Treatment (PROTECT-2), a Phase III, Randomized, Double-Blind Trial PROTECT-2 was a confirmatory efficacy and safety study designed to compare proposed biosimilar LA-EP2006 with reference pegfilgrastim in early-stage breast cancer patients receiving adjuvant or neoadjuvant myelosuppressive chemotherapy. [Oncologist] Abstract | Full Article Neratinib Plus Paclitaxel vs Trastuzumab plus Paclitaxel in Previously Untreated Metastatic ERBB2-Positive Breast Cancer: The NEfERT-T Randomized Clinical Trial Scientists determined whether neratinib, an irreversible pan-efficacious ERBB2 (formerly HER2 or HER2/neu) tyrosine kinase inhibitor, plus paclitaxel improves progression-free survival compared with trastuzumab plus paclitaxel in the first-line treatment of recurrent and/or metastatic ERBB2-positive breast cancer. [JAMA Oncol] Abstract |